CN103566028A - Traditional Chinese medicine composition for treating nasosinusitis - Google Patents
Traditional Chinese medicine composition for treating nasosinusitis Download PDFInfo
- Publication number
- CN103566028A CN103566028A CN201310507795.0A CN201310507795A CN103566028A CN 103566028 A CN103566028 A CN 103566028A CN 201310507795 A CN201310507795 A CN 201310507795A CN 103566028 A CN103566028 A CN 103566028A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 16
- 201000009890 sinusitis Diseases 0.000 claims description 14
- 241000555712 Forsythia Species 0.000 claims description 8
- 241000245240 Lonicera Species 0.000 claims description 8
- 235000014435 Mentha Nutrition 0.000 claims description 8
- 241001072983 Mentha Species 0.000 claims description 8
- 241000545442 Radix Species 0.000 claims description 8
- 241001180876 Saposhnikovia Species 0.000 claims description 8
- 241001530126 Scrophularia Species 0.000 claims description 8
- 241000207929 Scutellaria Species 0.000 claims description 8
- 239000009670 cang er zi wan Substances 0.000 claims description 8
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 4
- 230000001154 acute effect Effects 0.000 abstract description 5
- 230000001684 chronic effect Effects 0.000 abstract description 4
- 208000002173 dizziness Diseases 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 206010011224 Cough Diseases 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 206010028735 Nasal congestion Diseases 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 244000067505 Xanthium strumarium Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 206010009137 Chronic sinusitis Diseases 0.000 description 4
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 206010001076 Acute sinusitis Diseases 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010050515 Hyposmia Diseases 0.000 description 1
- 206010067994 Mucosal atrophy Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 208000027407 head symptom Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000019559 hyposmia Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating nasosinusitis. The traditional Chinese medicine composition is a medicament prepared from the following traditional Chinese medicine raw materials in parts by weight: 5-10 parts of cocklebur fruits, 5-10 parts of radix angelicae, 1-3 parts of asarum, 5-10 parts of rhizome chuanxiong, 5-10 parts of madder, 10-30 parts of salvia miltiorrhiza, 1-5 parts of schizonepeta, 5-10 parts of radix saposhnikoviae, 5-10 parts of chrysanthemum, 5-10 parts of honeysuckle, 5-10 parts of fructus forsythiae, 5-10 parts of liquorice, 10-30 parts of houttuynia cordata, 1-5 parts of bear gall powder, 10-30 parts of scutellaria baicalensis, 2-5 parts of mint, 5-10 parts of orange peels, 10-20 parts of radix scrophulariae, 10-20 parts of radix rehmanniae, 10-20 parts of angelica sinensis, 10-20 parts of platycodon grandiflorus and 10-20 parts of radix bupleuri. The traditional Chinese medicine composition for treating nasosinusitis, disclosed by the invention, is reasonable in formula and suitable for symptoms such as nasal congestion, rhinocnesmus, sternutation, snot, cough, dizziness, scatterbrain and the like caused by acute or chronic nasosinusitis.
Description
Technical field
The invention belongs to medical technical field, be specifically related to a kind of Chinese medicine composition for the treatment of sinusitis.
Background technology
Chronic sinusitis is common clinical, frequently-occurring disease, and main manifestations is the symptoms such as nasal obstruction, watery nasal discharge, dizziness, a vexed pain, hyposmia, absent minded, hypomnesis, has a strong impact on patient's study, life.The morbidity of chronic sinusitis is the coefficient result of multiple paathogenic factor, comprise that local pathogenic infection, body allergy increase, microcirculation disturbance mouth sinotunnel c omplex deformity and general immunity power low inferior, cause nasal mucosa edema, thicken and Polypoid changes, Cystic changes, or proliferation of fibrous tissue, angiemphraxis, body of gland atrophy, mucosal atrophy.
At present, Drug therapy for sinusitis comprises chemotherapy and treatment by Chinese herbs, the former is mainly symptomatic treatment, substantially comprise that the medicine that shrinks nose bleeding pipe is if ephedrine, Loratadine are as cetirizine etc. and steroid hormone spray nasal preparation, these chemicalses all have side effect in various degree; The latter is because side effect is little, for etiological treatment thereby met preferably the medication demand of clinical patients.The herbal species that is used for the treatment of now sinusitis in technology is various, but lacks the medicine that therapeutic effect is really supported by irrefutable evidence, and mostly treats in the Chinese medicine composition of sinusitis composition simple, and uncertain therapeutic efficacy is cut.
Summary of the invention
The Chinese medicine composition that the object of this invention is to provide a kind for the treatment of sinusitis reasonable, curative effect is reliable, side effect is little of filling a prescription.
For solving the problems of the technologies described above, the technical solution adopted in the present invention is as follows:
Treat a Chinese medicine composition for sinusitis, the medicament that this Chinese medicine composition is made by the raw material of Chinese medicine of following weight parts:
5～10 parts of Fructus Xanthii, 5～10 parts of the Radixs Angelicae Dahuricae, 1～3 part of Herba Asari, 5～10 parts of Rhizoma Chuanxiongs, 5～10 parts, Radix Rubiae, 10～30 parts of Radix Salviae Miltiorrhizaes, 1～5 part of Herba Schizonepetae, 5～10 parts of Radix Saposhnikoviaes, 5～10 parts of Flos Chrysanthemis, 5～10 parts of Flos Loniceraes, 5～10 parts of Fructus Forsythiaes, 5～10 parts, Radix Glycyrrhizae, 10～30 parts of Herba Houttuyniae, 1～5 part of Fel Ursi powder, 10～30 parts of Radix Scutellariaes, 2～5 parts of Herba Menthaes, 5～10 parts of Pericarpium Citri Reticulataes, 10～20 parts of Radix Scrophulariaes, 10～20 parts, the Radix Rehmanniae, 10～20 parts of Radix Angelicae Sinensis, 10～20 parts of Radix Platycodoniss, 10～20 parts of Radix Bupleuri.
Preferably, the medicament that above-mentioned Chinese medicine composition is made by the raw material of Chinese medicine of following weight parts:
8 parts of Fructus Xanthii, 8 parts of the Radixs Angelicae Dahuricae, 2 parts of Herba Asaris, 8 parts of Rhizoma Chuanxiongs, 8 parts, Radix Rubiae, 20 parts of Radix Salviae Miltiorrhizaes, 2 parts of Herba Schizonepetae, 8 parts of Radix Saposhnikoviaes, 8 parts of Flos Chrysanthemis, 8 parts of Flos Loniceraes, 8 parts of Fructus Forsythiaes, 8 parts, Radix Glycyrrhizae, 20 parts of Herba Houttuyniae, 3 parts of Fel Ursi powders, 20 parts of Radix Scutellariaes, 3 parts of Herba Menthaes, 8 parts of Pericarpium Citri Reticulataes, 15 parts of Radix Scrophulariaes, 15 parts, the Radix Rehmanniae, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Platycodoniss, 15 parts of Radix Bupleuri.
The capsule of above-mentioned medicament for requiring to make according to pharmacopeia.
The formula of the treatment acute and chronic nasal sinusitis Chinese medicine composition the present invention relates to is reasonable, be applicable to nasal obstruction, rhinocnesmus, sneeze, snivel, cough, giddy, energy that acute and chronic sinusitis causes and the symptom such as do not concentrate, be specially adapted to alleviate dizzy due to sinusitis, feeling of fullness in the head symptom and patients with chronic sinusitis and take for a long time.Capsule has not only improved the stability of medicine, simultaneously easy to carry and use, can improve rhinitis patient compliance.
The specific embodiment
For ease of understanding the present invention, it is as follows that the present invention enumerates embodiment.Those skilled in the art should understand, described embodiment only, for helping to understand the present invention, should not be considered as concrete restriction of the present invention.
Embodiment 1
8 parts of Fructus Xanthii, 8 parts of the Radixs Angelicae Dahuricae, 2 parts of Herba Asaris, 8 parts of Rhizoma Chuanxiongs, 8 parts, Radix Rubiae, 20 parts of Radix Salviae Miltiorrhizaes, 2 parts of Herba Schizonepetae, 8 parts of Radix Saposhnikoviaes, 8 parts of Flos Chrysanthemis, 8 parts of Flos Loniceraes, 8 parts of Fructus Forsythiaes, 8 parts, Radix Glycyrrhizae, 20 parts of Herba Houttuyniae, 3 parts of Fel Ursi powders, 20 parts of Radix Scutellariaes, 3 parts of Herba Menthaes, 8 parts of Pericarpium Citri Reticulataes, 15 parts of Radix Scrophulariaes, 15 parts, the Radix Rehmanniae, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Platycodoniss, 15 parts of Radix Bupleuri.
For showing the therapeutic effect of medicine of the present invention to acute and chronic nasal sinusitis, the present invention is as follows through clinical test results:
Selected case is all taken capsule prepared by the present embodiment, three times on the one, one time 3 (every is 0.3 gram), bfore meals, treatment acute and chronic nasal sinusitis patient 100 examples, took Chinese medicine composition of the present invention after 1 month, effective 72 examples (72%), effective 12 examples (12%), invalid 16 examples (16%), total effective rate is 84%.
Embodiment 2
Formula is: 10 parts of Fructus Xanthii, 10 parts of the Radixs Angelicae Dahuricae, 3 parts of Herba Asaris, 10 parts of Rhizoma Chuanxiongs, 10 parts, Radix Rubiae, 30 parts of Radix Salviae Miltiorrhizaes, 5 parts of Herba Schizonepetae, 10 parts of Radix Saposhnikoviaes, 10 parts of Flos Chrysanthemis, 10 parts of Flos Loniceraes, 10 parts of Fructus Forsythiaes, 10 parts, Radix Glycyrrhizae, 30 parts of Herba Houttuyniae, 5 parts of Fel Ursi powders, 30 parts of Radix Scutellariaes, 5 parts of Herba Menthaes, Pericarpium Citri Reticulatae～10 part, 20 parts of Radix Scrophulariaes, 20 parts, the Radix Rehmanniae, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Platycodoniss, 20 parts of Radix Bupleuri.
Embodiment 3
Formula is: 5 parts of Fructus Xanthii, 5 parts of the Radixs Angelicae Dahuricae, 1 part of Herba Asari, 5 parts of Rhizoma Chuanxiongs, 5 parts, Radix Rubiae, 10 parts of Radix Salviae Miltiorrhizaes, 1 part of Herba Schizonepetae, 5 parts of Radix Saposhnikoviaes, 5 parts of Flos Chrysanthemis, 5 parts of Flos Loniceraes, 5 parts of Fructus Forsythiaes, 5 parts, Radix Glycyrrhizae, 10 parts of Herba Houttuyniae, 1 part of Fel Ursi powder, 10 parts of Radix Scutellariaes, 2 parts of Herba Menthaes, 5 parts of Pericarpium Citri Reticulataes, 10 parts of Radix Scrophulariaes, 10 parts, the Radix Rehmanniae, 10 parts of Radix Angelicae Sinensis, 10 parts of Radix Platycodoniss, 10 parts of Radix Bupleuri.
Embodiment 4
Formula is: 8 parts of Fructus Xanthii, 8 parts of the Radixs Angelicae Dahuricae, 2 parts of Herba Asaris, 8 parts of Rhizoma Chuanxiongs, 8 parts, Radix Rubiae, 20 parts of Radix Salviae Miltiorrhizaes, 2 parts of Herba Schizonepetae, 8 parts of Radix Saposhnikoviaes, 8 parts of Flos Chrysanthemis, 8 parts of Flos Loniceraes, 8 parts of Fructus Forsythiaes, 8 parts, Radix Glycyrrhizae, 20 parts of Herba Houttuyniae, 5 parts of Fel Ursi powders, 30 parts of Radix Scutellariaes, 5 parts of Herba Menthaes, 10 parts of Pericarpium Citri Reticulataes, 20 parts of Radix Scrophulariaes, 20 parts, the Radix Rehmanniae, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Platycodoniss, 20 parts of Radix Bupleuri.
Applicant's statement, person of ordinary skill in the field is on the basis of above-described embodiment, by the concrete content point value of above-described embodiment component, combined with the technical scheme of summary of the invention part, thereby the new numerical range producing, also be one of record scope of the present invention, the application, for making description simple and clear, is no longer enumerated these numerical rangies.
Claims (3)
1. a Chinese medicine composition for the treatment of sinusitis, is characterized in that, the medicament that this Chinese medicine composition is made by the raw material of Chinese medicine of following weight parts:
5～10 parts of Fructus Xanthii, 5～10 parts of the Radixs Angelicae Dahuricae, 1～3 part of Herba Asari, 5～10 parts of Rhizoma Chuanxiongs, 5～10 parts, Radix Rubiae, 10～30 parts of Radix Salviae Miltiorrhizaes, 1～5 part of Herba Schizonepetae, 5～10 parts of Radix Saposhnikoviaes, 5～10 parts of Flos Chrysanthemis, 5～10 parts of Flos Loniceraes, 5～10 parts of Fructus Forsythiaes, 5～10 parts, Radix Glycyrrhizae, 10～30 parts of Herba Houttuyniae, 1～5 part of Fel Ursi powder, 10～30 parts of Radix Scutellariaes, 2～5 parts of Herba Menthaes, 5～10 parts of Pericarpium Citri Reticulataes, 10～20 parts of Radix Scrophulariaes, 10～20 parts, the Radix Rehmanniae, 10～20 parts of Radix Angelicae Sinensis, 10～20 parts of Radix Platycodoniss, 10～20 parts of Radix Bupleuri.
2. according to a kind of Chinese medicine composition for the treatment of sinusitis claimed in claim 1, it is characterized in that the medicament that described Chinese medicine composition is made by the raw material of Chinese medicine of following weight parts:
8 parts of Fructus Xanthii, 8 parts of the Radixs Angelicae Dahuricae, 2 parts of Herba Asaris, 8 parts of Rhizoma Chuanxiongs, 8 parts, Radix Rubiae, 20 parts of Radix Salviae Miltiorrhizaes, 2 parts of Herba Schizonepetae, 8 parts of Radix Saposhnikoviaes, 8 parts of Flos Chrysanthemis, 8 parts of Flos Loniceraes, 8 parts of Fructus Forsythiaes, 8 parts, Radix Glycyrrhizae, 20 parts of Herba Houttuyniae, 3 parts of Fel Ursi powders, 20 parts of Radix Scutellariaes, 3 parts of Herba Menthaes, 8 parts of Pericarpium Citri Reticulataes, 15 parts of Radix Scrophulariaes, 15 parts, the Radix Rehmanniae, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Platycodoniss, 15 parts of Radix Bupleuri.
3. according to a kind of Chinese medicine composition for the treatment of sinusitis claimed in claim 1, it is characterized in that: described medicament is capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310507795.0A CN103566028A (en) | 2013-10-24 | 2013-10-24 | Traditional Chinese medicine composition for treating nasosinusitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310507795.0A CN103566028A (en) | 2013-10-24 | 2013-10-24 | Traditional Chinese medicine composition for treating nasosinusitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103566028A true CN103566028A (en) | 2014-02-12 |
Family
ID=50039309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310507795.0A Pending CN103566028A (en) | 2013-10-24 | 2013-10-24 | Traditional Chinese medicine composition for treating nasosinusitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103566028A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104147194A (en) * | 2014-08-26 | 2014-11-19 | 王深涧 | Traditional Chinese medicine composition for treating chronic sinusitis |
| CN106177423A (en) * | 2016-08-31 | 2016-12-07 | 张超英 | A kind of rhinitis and nasosinusitis for the treatment of resists to treat the Chinese medicine of nasal sinusitis cancer |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6524627B1 (en) * | 2002-03-20 | 2003-02-25 | Daehan Biolink Co., Ltd. | Pharmaceutical composition for preventing and treating allergic diseases and a method for preparation thereof |
| US20050100616A1 (en) * | 2002-04-22 | 2005-05-12 | Matsuura Yakugyo Co., Ltd. | Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof |
| CN101926901A (en) * | 2010-09-01 | 2010-12-29 | 吴业刚 | Chinese medicinal oral liquid for treating chronic rhinitis and sinusitis and preparation method thereof |
| CN102228543A (en) * | 2011-07-05 | 2011-11-02 | 河南科技大学 | Chinese medicinal composition for treating rhinitis and nasosinusitis and preparation method thereof |
| CN102614306A (en) * | 2012-04-18 | 2012-08-01 | 刘洪波 | Traditional Chinese herbal preparation for treating chronic nasosinusitis |
-
2013
- 2013-10-24 CN CN201310507795.0A patent/CN103566028A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6524627B1 (en) * | 2002-03-20 | 2003-02-25 | Daehan Biolink Co., Ltd. | Pharmaceutical composition for preventing and treating allergic diseases and a method for preparation thereof |
| US20050100616A1 (en) * | 2002-04-22 | 2005-05-12 | Matsuura Yakugyo Co., Ltd. | Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof |
| CN101926901A (en) * | 2010-09-01 | 2010-12-29 | 吴业刚 | Chinese medicinal oral liquid for treating chronic rhinitis and sinusitis and preparation method thereof |
| CN102228543A (en) * | 2011-07-05 | 2011-11-02 | 河南科技大学 | Chinese medicinal composition for treating rhinitis and nasosinusitis and preparation method thereof |
| CN102614306A (en) * | 2012-04-18 | 2012-08-01 | 刘洪波 | Traditional Chinese herbal preparation for treating chronic nasosinusitis |
Non-Patent Citations (2)
| Title |
|---|
| 唐成定等: "银花通窍鼻炎汤治疗慢性鼻窦炎50例", 《河南中医》, vol. 29, no. 11, 30 November 2009 (2009-11-30) * |
| 国家食品药品监督管理局: "《国食药监注[2005]110号》", 21 March 2005, article "关于进一步加强麝、熊资源保护及其产品入药管理的通知" * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104147194A (en) * | 2014-08-26 | 2014-11-19 | 王深涧 | Traditional Chinese medicine composition for treating chronic sinusitis |
| CN104147194B (en) * | 2014-08-26 | 2015-07-22 | 陈红 | Traditional Chinese medicine composition for treating chronic sinusitis |
| CN106177423A (en) * | 2016-08-31 | 2016-12-07 | 张超英 | A kind of rhinitis and nasosinusitis for the treatment of resists to treat the Chinese medicine of nasal sinusitis cancer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104127496A (en) | Rhinitis and nasosinusitis treatment medicine | |
| CN103566009A (en) | Traditional Chinese medicine (TCM) composition for treating acute and chronic rhinitis | |
| CN103446554A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN102309691A (en) | Traditional Chinese medicine prescription for treating post-partum night sweat | |
| CN104623516A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN103566028A (en) | Traditional Chinese medicine composition for treating nasosinusitis | |
| CN102247452A (en) | Prescription for treating influenza | |
| CN103566344A (en) | Blood-invigorating and muscles and joints-relaxing paste | |
| CN103536646A (en) | Medicine of drug pillow interior for treating insomnia | |
| CN102274395A (en) | Traditional Chinese medicine for treating rhinitis | |
| CN104758529A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
| CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
| CN103566298B (en) | Plaster with wind dispelling and dampness eliminating effects | |
| CN103083493A (en) | Treatment method of rhinitis by using Chinese medicaments | |
| CN104815284A (en) | Traditional Chinese medicinal composition for treating nasal polyp | |
| CN104398915A (en) | Traditional Chinese medicinal composition for chronic eczema | |
| CN103566219A (en) | Traditional Chinese medicine composition for treating cold | |
| CN104740394A (en) | Respiratory tract infection drug | |
| CN101897923A (en) | Chinese medicinal powder for treating nighttime lumbago | |
| CN103933504A (en) | Traditional Chinese medicine for treating acute rhinitis | |
| CN105055580A (en) | Traditional Chinese medicine for treating cold | |
| CN104116931A (en) | Traditional Chinese medicinal composition for treating nervous headache | |
| CN102370841A (en) | Chinese herbal prescription for treating stagnation of qi due to depression of liver in later menstrual period | |
| CN104027615A (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN104547292A (en) | Compound medicine for treating chronic rhinitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140212 |